ArticleFrontiers in pharmacology2021

Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma.

Caterina Gianni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.